Description:

Amazon.com Review

Jayne Ann Krentz and Catherine Coulter: Author One-on-One
In this Amazon exclusive, we brought together blockbuster authors

The author of over 40 consecutive New York Times bestsellers, Read on to see Jayne Ann Krentz's questions for Catherine Coulter, or

Jayne: You have a fabulously successful career going in two genres, romance and suspense. Why do you write both? What are the elements in each genre that excite and compel you as an author?

Catherine: Do you know, I love to write both genres because they are so very different from each other, and that means, frankly, that I’ll never run out of creative gas or get myself stuck in a burn-out hole. In most of my historical romances (just like yours) there are mysteries because my mind simply works that way (just like yours). To be defined as a romance, the relationship between the man and the woman must be at the center. And as you know, in suspense thrillers, unlike romances, it’s the gnarly situations that are at the center, and the love story?and there usually is one, because relationships are at the center of life?, is at the periphery. In the thrillers, I’m focused on pacing (i.e., making the reader turn that page), and juggling two different gnarly situations. And maybe, if I’m blessed, I can go back and forth, stretching the denouement for both to a good hundred pages.

Jayne:When you wrote the wildly successful book

Catherine: Lots of writers had branched out before I got into the FBI series. The Cove marked the first of the FBI series, but at that time I had no idea that this book was a kick-off for a series. It simply evolved. Because of its success, Putnam wanted me to drop historical romances and stick to suspense thrillers. No way was that going to happen: I love historicals, the humor, the mysteries, the history, the cat races, for heaven’s sake! I struck a deal with my publisher: One historical romance, then one suspense thriller. You said you were a happy camper—move over, I’m right with you.

Jayne:There’s a bit of a psychic vibe in many of your books. Where does that come from, and why do you like to plot with that element?

Catherine: People are fascinated with psychic stuff. Just look at TV shows and movies—_Medium, Ghost Whisperer, The X-Files, Lost_, and anything with vampires, like Twilight, The Vampire Diaries. And even Harry Potter. We all love stuff we can’t explain, stuff that’s different from what’s real in our daily lives. From one woo-woo lover to another, ain’t it great?!

Jayne:What is the future of the FBI series? Any plans for firing up a new suspense series?

Catherine: I’m now writing the fifteenth (count ’em, fifteen) FBI, titled Split Second. That's a whole lot of Savich and Sherlock. My prayer is that I will realize when enough is enough. So far, things still look good.

Jayne: Did you really grow up on a horse farm in Texas?

Catherine: Yep, quarter horses.

(Photo of Catherine Coulter © Charles Bush)
(Photo of Jayne Ann Krentz © Sigrid Estrada)

From Publishers Weekly

In Coulter's fab 14th FBI paranormal romantic thriller (after KnockOut), FBI special agents Dillon Savich and his wife, Lacey Sherlock, look into the possible haunting of a U.S. senator by his dead wife as well as a more earthly crime: Germany's Schiffer Hartwin Pharmaceutical, which has its U.S. headquarters in Connecticut, might be deliberately withholding an inexpensive cancer fighting drug, Culovort, to force cancer patients to require the far more expensive Eloxium, in short supply. The FBI probe dovetails with one by PI and part-time ballet teacher Erin Pulaski, who's hired by a Yale professor worried about his cancer-stricken father being affected by the shortage. In a wild coincidence, Bowie Richards, the FBI special agent in charge of the New Haven field office, also hires Erin—to babysit his daughter, a ballet student of hers. The attraction between Bowie and Erin grows as they help Dillon and Lacey crack a complicated double case. Coulter fans will want to see more of this new crime-fighting duo. (June)
Copyright © Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.